Development

INSIGHTS ON DRUG DEVELOPMENT

From 51% Yield To 87% With Targeted Impurity Removal
Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.
Thermofluor Screening For Injectable Protein Formulations
The results herein highlight thermofluor screening as a versatile and efficient platform for rational formulation of injectable biologics through the acceleration of stable drug product development.
How One Biotech Company Is Accelerating The Drug Discovery Workflow
See how biotech innovation is accelerating drug discovery through AI, miniaturized workflows, and collaborative technologies to reshape how therapies are developed and delivered.
Using AI-Analysis And High-Content Screening To Improve Data Capturing
Discover an advanced 3D imaging for drug discovery that features high-throughput, high-quality images, modular hardware, and intuitive software for precise, rapid analysis.

Versatile Lipid Nanoparticle Platform For Efficient Gene Editing
6/3/2025

Lipid nanoparticles enable efficient gene editing in hard-to-transfect cells like T-cells and blood stem cells, which offers scalable, clinically relevant methods for developing advanced therapies for cancer and rare diseases.
Color Consistency In UHMWPE Medical Textiles
3/26/2026

Color consistency improves surgical visibility, differentiation, and workflow efficiency, requiring medical textiles that deliver strength, compliance, and reliable quality in every color.
Lonza Advanced Synthesis Capabilities Update February 2026: AI Drug Development
3/2/2026

Learn how our scientists accurately predict and identify the most stable cocrystal forms by leveraging advanced machine learning models, enhancing efficiency and reducing development risks.
Solving Formulation Challenges Across Modalities
6/15/2026

Optimize drug delivery by leveraging advanced nanoparticle engineering to dramatically increase small-molecule oral drug loading and enable ultra-high-concentration subcutaneous formulations.
Glucagon-Like Peptide-1 (GLP-1) Analogues Applications Notebook
12/11/2025

View this collection of application notes about the chromatographic analysis and purification of GLP-1 analogues, including Semaglutide, Tirzepatide, Liraglutide, and Exenatide.

Advancing Nitrosamine Testing For Evolving Regulations

Explore how specialized analytical expertise and advanced instrumentation enable precise nitrosamine testing to help drug developers meet strict and evolving regulatory requirements.
Premium Tools For Diabetes Research

Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels due to inadequate insulin production or impaired insulin utilization, commonly known as insulin resistance.
FlexUP Technology Renewal Program

Are you using obsolete or aging instruments simply because they continue to work? Running your laboratory with outdated technology brings about challenges beyond just headaches. Older technology may limit your performance, increase your costs, and open your lab up to risk. It may be time to investigate the real cost of using obsolete technology.

With the Waters FlexUP Technology Renewal Program, always work with the latest technology for optimum productivity and security.
AUC Sample Characterization Instrument
- Enables sample recovery
- Avoids dilution effects
- Analyzes samples in a matrix-free environment
- Has minimal buffer constraints
From Process Development To QC—Optimize Your mAbs Workflow

See how integrated analytical capabilities help improve visibility across mAb workflows, enabling faster decisions, stronger process control, and reliable quality outcomes from development through QC.